NOTE TO INVESTORS: The latest news and updates relating to TCBP are available in the company's newsroom at ...
Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment ...
The transformative capacity of cells as therapeutics has revolutionised malignancy treatments.1 Cellular engineering advances ...
Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early ...
Headlands Research, a clinical trial site network with locations across the United States and Canada, is launching its newest ...
Zacks Small Cap Research on MSN8h
V.MDCX: Medicus Pharma Randomizes First Patient in SKNJCT-003 Phase 2 clinical trial for the treatment of nodular BCC (Basal Cell Carcinoma).MDCX READ THE FULL V.MDCX RESEARCH REPORT First Patient Randomized for Medicus Pharma’s Phase 2 Clinical Study (SKNJCT-003) ...
Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...
The following is a summary of “Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges,” published in the ...
The integration of artificial intelligence (AI) in the radiotherapy of pelvic and abdominal malignancies represents a transformative advancement in oncology. AI's capability to enhance precision in ...
New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback